anmelden
OMX Stockholm 30
3.292,34
PKT
+34,01
PKT
+1,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.07.17 | AstraZeneca Hold | S&P Capital IQ | |
| 27.07.17 | Volvo (B) Neutral | UBS AG | |
| 27.07.17 | AstraZeneca Neutral | UBS AG | |
| 25.07.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 24.07.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 21.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 21.07.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 21.07.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 21.07.17 | ABB (Asea Brown Boveri) Hold | Kepler Cheuvreux | |
| 21.07.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 20.07.17 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 20.07.17 | ABB (Asea Brown Boveri) Hold | S&P Capital IQ | |
| 20.07.17 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 17.07.17 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 14.07.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.07.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 13.07.17 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 13.07.17 | AstraZeneca buy | Citigroup Corp. | |
| 13.07.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 13.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 12.07.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 11.07.17 | Ericsson (Telefon L.M.Ericsson) (B) buy | Goldman Sachs Group Inc. | |
| 10.07.17 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 05.07.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 05.07.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 05.07.17 | AstraZeneca buy | Citigroup Corp. | |
| 03.07.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 03.07.17 | AstraZeneca overweight | Barclays Capital | |
| 30.06.17 | AstraZeneca buy | Deutsche Bank AG | |
| 29.06.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 27.06.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 27.06.17 | AstraZeneca Neutral | UBS AG | |
| 23.06.17 | AstraZeneca overweight | Morgan Stanley | |
| 22.06.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 20.06.17 | Ericsson (Telefon L.M.Ericsson) (B) Equal-Weight | Morgan Stanley | |
| 16.06.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 13.06.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 09.06.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 09.06.17 | Ericsson (Telefon L.M.Ericsson) (B) buy | Citigroup Corp. | |
| 07.06.17 | AstraZeneca Neutral | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.
